Literature DB >> 15581157

Neurocognitive profiles in Salla disease.

Liisa Alajoki1, Tarja Varho, Kristiina Posti, Pertti Aula, Tapio Korhonen.   

Abstract

Salla disease, a free sialic acid storage disorder, is one of the 36 currently known disorders in Finland that form the Finnish disease heritage. Salla disease leads to learning disability* with a wide clinical variation. Two main categories of the disease have been classified: a conventional subtype and a severe subtype with more severe defects. We present detailed neurocognitive profiles of 41 Finnish patients with Salla disease (19 females, 22 males; age range 11mo to 63y, median 19y). The neurocognitive development of patients with Salla disease was assessed by psychological and neuropsychological testing. All patients were also examined by a paediatric neurologist and a speech therapist. The characteristic cognitive profile consisted of a lower non-verbal performance (mean developmental age 13mo) compared with linguistic skills (mean developmental age 17mo). In particular, spatial and visual-constructive impairments were typical of these patients. Tactile and visual discrimination of forms was poor. Tasks demanding hand-eye coordination, maintenance of visual attention, and those requiring short-term visual memory and executive skills were performed better. Receptive language skills were notably better compared with expressive speech. The patients' interactive and non-verbal communication skills were quite strong. Another typical pattern with Salla disease was severe motor disability. After the second decade of life, the decline in these skills was more pronounced than patients' cognitive deterioration. Our results indicate that even though there is a considerable variation in the clinical findings of patients with Salla disease, the characteristic neurocognitive profile of the disease can be outlined.

Entities:  

Mesh:

Year:  2004        PMID: 15581157     DOI: 10.1017/s0012162204001458

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  5 in total

1.  Identification of a vesicular aspartate transporter.

Authors:  Takaaki Miyaji; Noriko Echigo; Miki Hiasa; Shigenori Senoh; Hiroshi Omote; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

Review 2.  Free sialic acid storage disorder: Progress and promise.

Authors:  Marjan Huizing; Mary E Hackbarth; David R Adams; Melissa Wasserstein; Marc C Patterson; Steven U Walkley; William A Gahl
Journal:  Neurosci Lett       Date:  2021-04-20       Impact factor: 3.046

3.  A 13-year follow-up of Finnish patients with Salla disease.

Authors:  Liisa E Paavola; Anne M Remes; Marika J Harila; Tarja T Varho; Tapio T Korhonen; Kari Majamaa
Journal:  J Neurodev Disord       Date:  2015-07-13       Impact factor: 4.025

4.  Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.

Authors:  R Biancheri; A Rossi; H A Verbeek; R Schot; F Corsolini; S Assereto; G M S Mancini; F W Verheijen; C Minetti; M Filocamo
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

5.  An Unusual Developmental Profile of Salla Disease in a Patient with the SallaFIN Mutation.

Authors:  Liisa E Paavola; Anne M Remes; Pirkko H Sonninen; Vesa V Kiviniemi; Tapio T Korhonen; Kari Majamaa
Journal:  Case Rep Neurol Med       Date:  2012-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.